Raynaud's Disease
Raynaud's Disease ( 33 Questions)
Beta-blockers are not commonly prescribed for Raynaud's disease. In fact, they may worsen the condition by causing vasoconstriction.
Antihistamines are not used to manage Raynaud's disease. They primarily target histamine receptors and are not effective in improving blood flow.
Oral corticosteroids are not typically used to manage Raynaud's disease. They have anti-inflammatory effects but are not effective in treating the underlying vascular dysfunction of Raynaud's.
Calcium channel blockers, such as nifedipine or amlodipine, are commonly prescribed for Raynaud's disease. These medications help relax and dilate blood vessels, improving blood flow to the extremities and reducing the frequency and severity of Raynaud's episodes.
A) Beta-blockers are not commonly prescribed for Raynaud's disease. In fact, they may worsen the condition by causing vasoconstriction.
B) Antihistamines are not used to manage Raynaud's disease. They primarily target histamine receptors and are not effective in improving blood flow.
C) Oral corticosteroids are not typically used to manage Raynaud's disease. They have anti-inflammatory effects but are not effective in treating the underlying vascular dysfunction of Raynaud's.
D) Calcium channel blockers, such as nifedipine or amlodipine, are commonly prescribed for Raynaud's disease. These medications help relax and dilate blood vessels, improving blood flow to the extremities and reducing the frequency and severity of Raynaud's episodes.